Healthcare provider profile · identity verified

Dennis Caffery

Family Practice · HOPEDALE, IL · NPI 1295825594

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	467	133
Levothyroxine Sodium	Levothyroxine Sodium	255	66
Lisinopril	Lisinopril	241	63
Omeprazole	Omeprazole	234	66
Gabapentin	Gabapentin	197	48
Tamsulosin Hcl	Tamsulosin Hcl	193	57
Losartan Potassium	Losartan Potassium	185	49
Pantoprazole Sodium	Pantoprazole Sodium	178	44
Amlodipine Besylate	Amlodipine Besylate	167	47
Tramadol Hcl	Tramadol Hcl	163	36
Metformin Hcl	Metformin Hcl	160	46
Metoprolol Succinate	Metoprolol Succinate	150	40
Pravastatin Sodium	Pravastatin Sodium	144	31
Metoprolol Tartrate	Metoprolol Tartrate	140	40
Hydrochlorothiazide	Hydrochlorothiazide	137	40
Eliquis	Apixaban	125	29
Albuterol Sulfate Hfa	Albuterol Sulfate	122	34
Alprazolam	Alprazolam	108	20
Furosemide	Furosemide	107	31
Sertraline Hcl	Sertraline Hcl	102	32
Rosuvastatin Calcium	Rosuvastatin Calcium	96	33
Montelukast Sodium	Montelukast Sodium	86	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	11
Buspirone Hcl	Buspirone Hcl	81	19
Escitalopram Oxalate	Escitalopram Oxalate	80	19
Metformin Hcl Er	Metformin Hcl	77	15
Amitriptyline Hcl	Amitriptyline Hcl	74	12
Baclofen	Baclofen	72	18
Celecoxib	Celecoxib	70	17
Clopidogrel	Clopidogrel Bisulfate	70	22
Glimepiride	Glimepiride	70	19
Spironolactone	Spironolactone	70	19
Prednisone	Prednisone	67	34
Lorazepam	Lorazepam	66	13
Meloxicam	Meloxicam	66	16
Mirtazapine	Mirtazapine	66	18
Allopurinol	Allopurinol	65	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	64	17
Atenolol	Atenolol	63	16
Ventolin Hfa	Albuterol Sulfate	63	12
Pioglitazone Hcl	Pioglitazone Hcl	62	17
Alendronate Sodium	Alendronate Sodium	61	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	11
Clonazepam	Clonazepam	60	suppressed
Xarelto	Rivaroxaban	60	12
Triamcinolone Acetonide	Triamcinolone Acetonide	58	19
Glipizide	Glipizide	57	16
Jardiance	Empagliflozin	57	12
Duloxetine Hcl	Duloxetine Hcl	55	13
Citalopram Hbr	Citalopram Hydrobromide	54	11
Ozempic	Semaglutide	52	11
Finasteride	Finasteride	51	15
Trulicity	Dulaglutide	51	suppressed
Simvastatin	Simvastatin	50	12
Chlorthalidone	Chlorthalidone	48	13
Fluticasone Propionate	Fluticasone Propionate	47	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	15
Trazodone Hcl	Trazodone Hcl	47	14
Clonidine Hcl	Clonidine Hcl	46	suppressed
Tizanidine Hcl	Tizanidine Hcl	46	11
Ezetimibe	Ezetimibe	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	11
Carvedilol	Carvedilol	41	11
Metoclopramide Hcl	Metoclopramide Hcl	41	suppressed
Potassium Chloride	Potassium Chloride	40	12
Famotidine	Famotidine	39	suppressed
Glipizide Er	Glipizide	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Torsemide	Torsemide	36	suppressed
Mounjaro	Tirzepatide	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Topiramate	Topiramate	32	suppressed
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Digoxin	Digoxin	17	suppressed
Estradiol	Estradiol	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Minocycline Hcl	Minocycline Hcl	17	suppressed
Sulfasalazine	Sulfasalazine	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Azelastine Hcl	Azelastine Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Nitroglycerin	Nitroglycerin	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Cephalexin	Cephalexin	12	12
Irbesartan	Irbesartan	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error